This is the authors' abstract. We don't add key points for this paper.
In this study, collagen hydrolysate (CH) was prepared from Asian bullfrog skin using papain hydrolysis combined with ultrasound-assisted processing, and it exhibited notable immune-enhancing and anti-inflammatory properties in its undigested form. However, gastrointestinal (GI) digestion differentially influences these bioactivities. While the immune-stimulatory activity of digested CH (d-CH) is significantly reduced following digestion, its anti-inflammatory effects remain largely preserved. Structural profiling using size exclusion chromatography (SEC) with refractive index (RI) and ultraviolet (UV) detection revealed a heterogeneous distribution of collagen hydrolysate fractions in undigested CH, ranging from 12.7 to 117 kDa. Following simulated GI digestion, CH underwent extensive molecular breakdown, leading to the disappearance of higher-molecular-weight species and the emergence of a single, dominant low-molecular-weight fraction (∼4.2 kDa), indicative of a more uniform collagen-derived fraction composition and potentially improved accessibility for absorption. In an LPS-induced macrophage inflammation model, d-CH effectively suppressed key pro-inflammatory mediators, including nitric oxide (NO), COX-2, iNOS, IL-1β, IL-6, and TNF-α, while significantly upregulating the anti-inflammatory cytokine IL-10. Additionally, d-CH inhibited the activation of pivotal inflammatory signaling cascades such as NF-κB and MAPKs. Collectively, these findings underscore the importance of structural transformation during digestion in shaping the functional properties of CH and support its potential as a bioactive ingredient in functional foods or nutraceuticals aimed at mitigating inflammation-related disorders.
No takes yet. Share an insight, caveat, or question.
Surayot et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: